TICKERNERD
Menu
NNOXNNOXHealthcare · Medical Devices

NNOX Stock Forecast: Nano-X Imaging Ltd. Price Predictions for 2026-2027

Last close, 8 Oct 2026
$0.57
−4.82% on the day

The 3 Wall Street analysts covering Nano-X Imaging Ltd. hold a median 12-month price target of $4.4 — +677.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 18 of 100 as at 8 Oct 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$44.5M
Ticker Nerd rank
18 / 100
Median analyst target
$4.40
Analysts covering
3
Revenue$4.2M+36.7% y/y
Operating income−$55.5M
Net income−$55.5M
Free cash flow−$12.6M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−14.5%
1M
−39.1%
YTD
−79.8%
1Y
−86.9%
From 52W high
−87.6%
From 52W low
0.0%
$0.57
$4.55
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

NNOX stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Nano-X Imaging Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 8 Oct 2026
18 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
96
Size
82
Issuance
46
Growth
38
Revisions
27
Volatility
12
Value
9
Quality
7
Momentum
3

Accruals (96): Reported profit is backed by cash, and the company is not expanding recklessly.

Momentum (3): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

NNOX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NNOX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$1.00$2.00$3.00$4.00$5.00Jan 26Apr 26Jul 26Oct 26NNOXHigh $5.00Median $4.40Low $3.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says3 analysts
2 Buy1 Hold0 Sell
Low $3.00Median $4.40High $5.00

The green dot is the last close — the median target sits +677.0% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
17 Aug 2026Cantor FitzgeraldReiteratesOverweight$5.00
7 July 2026Alliance Global PartnersDowngradeNeutral$5.00 → $3.00
7 July 2026Alliance Global PartnersDowngradeNeutral—
20 Apr 2026D. Boral CapitalMaintainsBuy—
13 Apr 2026D. Boral CapitalMaintainsBuy—
3 Mar 2026D. Boral CapitalMaintainsBuy—
4 Feb 2026D. Boral CapitalMaintainsBuy—
20 Nov 2025D. Boral CapitalMaintainsBuy—
18 Nov 2025D. Boral CapitalMaintainsBuy—
19 Sept 2025D. Boral CapitalMaintainsBuy—
13 Aug 2025D. Boral CapitalMaintainsBuy—
6 June 2025D. Boral CapitalMaintainsBuy—
23 May 2025D. Boral CapitalMaintainsBuy—
17 Apr 2025D. Boral CapitalMaintainsBuy—
1 Apr 2025Cantor FitzgeraldMaintainsOverweight—
31 Mar 2025D. Boral CapitalMaintainsBuy—
25 Feb 2025D. Boral CapitalMaintainsBuy—
6 Jan 2025D. Boral CapitalInitiatesBuy—
6 Dec 2024Cantor FitzgeraldMaintainsOverweight—
26 Nov 2024Cantor FitzgeraldMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NNOX appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

NNOX vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 8 Oct 2026, Nano-X Imaging Ltd. returned −86.9% against +16.2% for the S&P 500, dividends included.

NNOX vs S&P 500, last 12 monthsTotal return, rebased to 100
020406080100120Jan 26Apr 26Jul 26Oct 26NNOXS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

NNOX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Nano-X Imaging Ltd. (NNOX) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−0.5×

Cheaper than 80% of US stocks

Price / sales
2.8×

Cheaper than 42% of US stocks

Price / book
0.5×

Cheaper than 83% of US stocks

EV / EBITDA
−0.4×

Cheaper than 64% of US stocks

Growth & margins
Revenue growth (YoY)
36.7%

Higher than 82% of US stocks

Earnings growth (YoY)
36.7%

Higher than 70% of US stocks

Gross margin
−1050.9%

Higher than 1% of US stocks

Operating margin
−355.3%

Higher than 9% of US stocks

Net margin
−98.2%

Higher than 6% of US stocks

Returns & dividend
Return on equity
−99.0%

Higher than 13% of US stocks

Return on assets
−27.9%

Higher than 15% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Nano-X Imaging Ltd. (NNOX) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Nano-X Imaging Ltd. has a market value of $44.5M and an enterprise value of $18.4M.

  • Revenue in the twelve months to 30 June 2026: $15.6M. The latest quarter grew 36.7% year on year.

  • Net income over the same four quarters: −$116.8M, a −747.2% net margin.

  • Diluted earnings per share, trailing twelve months: $−1.70.

  • Free cash flow in the twelve months to 30 June 2026: −$52.1M.

  • Shares outstanding: 70.1M.

  • Trailing P/E: −0.5×; forward P/E: −1.4× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Nano-X Imaging Ltd. employs 197 people — $79K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 9 Oct 2026

Data provided by Twelve Data

Peers

NNOX vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
NNOXNano-X Imaging Ltd.$44.5M
18
CVRXCVRx, Inc.$44.2M
29
XTNTXtant Medical Holdings, Inc.$45.0M
74
RPIDRapid Micro Biosystems, Inc.$42.9M
24
TELATELA Bio, Inc.$46.8M
34
SRTSSensus Healthcare, Inc.$48.9M
50
SNWVSANUWAVE Health, Inc.$50.1M
51

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Nano-X Imaging Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest NNOX news & analysis

Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

GlobeNewsWire · 10 Sept 2026positive

Nanox Imaging Ltd. announced a Nanox.ARC distribution agreement with SOLME RC, SA in Costa Rica, marking its third Latin American market entry this year. The announcement was made on September 10, 2026, from the company's Petach Tikva, Israel headquarters.

Why it matters — NNOX watchers would care because the agreement signals continued expansion of Nanox.ARC's commercial footprint into a new Latin American market, adding to the company's regional distribution momentum this year.

Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call Transcript

Seeking Alpha · 9 Sept 2026neutral

Seeking Alpha published the transcript of Nano-X Imaging Ltd.'s Q2 2026 earnings call, covering management's remarks and discussion with analysts during the company's quarterly results presentation.

Why it matters — The transcript gives NNOX watchers a direct record of management commentary on the company's latest quarterly performance and outlook.

Nano-X Imaging Q2 Earnings Call Highlights

MarketBeat · 9 Sept 2026neutral

Nano-X Imaging reported second-quarter 2026 revenue growth driven by its teleradiology, health IT and AI businesses. The company also recorded a substantial non-cash impairment charge and outlined cost-reduction actions intended to extend its cash runway.

Why it matters — The news is relevant to NNOX watchers because it combines Q2 revenue growth with an impairment charge and cost-cutting measures that could affect the company's financial position and liquidity.

Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates

GlobeNewsWire · 9 Sept 2026neutral

Nanox announced its financial results for the second quarter ended June 30, 2026, and provided a business update. The announcement covers the company's quarterly performance and ongoing operations.

Why it matters — A NNOX watcher would care because the quarterly results and business update offer the latest insight into the company's financial performance and strategic direction.

Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

GlobeNewsWire · 4 Sept 2026positive

Nano-X Imaging Ltd. announced that its U.S.-based subsidiary, Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp., a New England-based medical imaging equipment and services provider, to support deployment of the Nanox.ARC across the region. This expands Nanox's growing U.S. distribution network.

Why it matters — A NNOX watcher would care because this agreement broadens the company's U.S. distribution footprint for the Nanox.ARC through a regional New England partner.

FAQ

Frequently asked questions about NNOX stock

What is the NNOX stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Nano-X Imaging Ltd. have a median 12-month price target of $4.4, with estimates ranging from $3 to $5. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is NNOX stock a buy right now?

Of the 3 analysts covering Nano-X Imaging Ltd., 2 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Nano-X Imaging Ltd. 18 out of 100 across roughly 4,600 US stocks as at 8 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank NNOX?

As at 8 Oct 2026, Nano-X Imaging Ltd. ranks 18 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (96 of 100).

Will NNOX stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +677.0% from the last close, and Ticker Nerd's factor model ranks Nano-X Imaging Ltd. 18 out of 100 as at 8 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the NNOX stock forecast for 2030?

No analyst covering Nano-X Imaging Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NNOX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $3 to $5 over the next 12 months.

How has NNOX stock performed over the past year?

Nano-X Imaging Ltd. returned -86.9% over the 12 months to 8 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Nano-X Imaging Ltd. do?

Nano-X Imaging Ltd. Ordinary Shares represents the equity of Nano-X Imaging Ltd., a medical imaging technology company focused on developing and commercializing digital X-ray-based imaging systems and related healthcare services.

What is the latest news on NNOX?

The most recent item we track (GlobeNewsWire, 10 Sept 2026): "Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica". Nanox Imaging Ltd. announced a Nanox.ARC distribution agreement with SOLME RC, SA in Costa Rica, marking its third Latin American market entry this year. The announcement was made on September 10, 2026, from the company's Petach Tikva, Israel headquarters.

Company

About Nano-X Imaging Ltd.

Nano-X Imaging Ltd. Ordinary Shares represents the equity of Nano-X Imaging Ltd., a medical imaging technology company focused on developing and commercializing digital X-ray-based imaging systems and related healthcare services. The company’s current offerings center on the Nanox platform, which combines the Nanox.ARC imaging system with software and cloud-enabled tools such as Nanox.CLOUD for image management, radiologist workflow support, review, annotation, billing, and reporting. Nano-X Imaging also operates in AI-driven medical imaging applications and teleradiology services, serving healthcare providers that need diagnostic imaging solutions and connected service workflows. Headquartered in Petach Tikva, Israel, Nano-X Imaging Ltd. is positioned within the healthcare technology market, where its products are designed to broaden access to medical imaging and integrate hardware, software, and services into a single platform.

CEO Mr. Erez I. Z. Meltzer · 197 employees · Israel · https://www.nanox.vision